Genworth Financial (GNW) Looks Fully Priced As Q3 Loss And CEO Change Raise Questions

Why Genworth’s latest quarter matters for investors

Genworth Financial (GNW) just paired a third quarter net loss with news of an upcoming CEO handover, after also flagging pressure from its closed block long term care insurance portfolio.

The latest report showed third quarter revenue of US$1,794 million compared with US$1,935 million a year earlier, with a net loss of US$41 million replacing last year’s US$116 million profit.

The share price reaction has been cool rather than dramatic, with Genworth Financial down 11.22% on a 90 day share price return and 7.45% over the past month. However, the 5 year total shareholder return of 100.46% still points to a very strong longer term payoff for investors who stayed the course.

Scan how Genworth Financial’s mix of long term care pressure and buybacks compares with other insurers by reviewing our curated list of solid balance sheet and fundamentals (25 results)

Genworth Financial’s softer share price now sits between two stories: long term care losses and leadership change on one side, and aggressive buybacks and mortgage insurance resilience on the other. Which one are current valuations really pricing in?

Price-to-Earnings of 81.7x: Is it justified?

Valuation on Genworth Financial currently hinges on a rich P/E of 81.7x, which sits against a last close share price of $8.70 and relatively modest reported profitability.

The P/E ratio compares the share price with earnings per share. For an insurer like Genworth Financial, it reflects what the market is willing to pay today for each dollar of recent earnings, even though those earnings can swing sharply when long term care reserves or claims experience move.

A multiple of 81.7x suggests the market is assigning a high price tag to each dollar of current profit. Earnings have been under pressure, with profit margins at 0.5% compared with 3.4% a year earlier and earnings declining over both the past year and the past 5 years. That combination points to investors paying a steep price for a business that has not reported recent earnings growth, rather than a discount for volatility.

The comparison with peers is stark. The same 81.7x P/E sits against a peer average of 7.6x and a broader US Insurance industry average of 11.4x. The stock is therefore priced at a multiple that is many times higher than both its direct comparison group and the wider sector, which signals that the valuation is expensive relative to industry norms rather than in line with them.

See what the numbers say about this price — find out in our valuation breakdown.

Result: Preferred multiple of Price-to-Earnings of 81.7x (OVERVALUED)

Still, Genworth Financial faces clear threats if long term care losses deepen or if the CEO transition distracts management from executing on capital plans.

Find out about the key risks to this Genworth Financial narrative.

Next Steps

Given the mixed tone around Genworth Financial, it can be useful to examine the numbers yourself instead of relying on any single narrative. To pressure test your own thesis, review the 3 important warning signs.

Looking for more investment ideas beyond Genworth Financial?

Do not stop your research with Genworth Financial. Broader context from other high quality opportunities can sharpen your judgment and help you spot what the market is missing.

• Target resilient income by reviewing a curated group of income opportunities built around 7 dividend fortresses that combine yield with robust underlying businesses.
• Hunt for mispriced quality and pressure test your valuation instincts against our 19 high quality undiscovered gems before attention crowds in and potential edges fade.
• Prioritise steadier sleep at night and compare Genworth Financial with a 31 resilient stocks with low risk scores that filters for balance sheet strength and lower risk scores.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com